.Amgen has actually discussed (PDF) the 1st stage 3 records on its own $400 thousand dermatitis drug...
.Biogen and UCB's gamble on developing into period 3 on the back of a failed research study tries to...
.Italian biotech Aptadir Therapeutics has actually released along with the guarantee that its own pi...
.Surge Life Sciences has actually fulfilled its own goal in a Duchenne muscular dystrophy (DMD) rese...
.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, usi...
.Achilles Rehabs has actually torn up its tactic. The British biotech is knocking off on its clinica...
.Aligos Therapeutics is advertising a midstage win in metabolic-dysfunction associated steatohepatit...
.Basilea Pharmaceutica's job establishing new antifungals has obtained a considerable improvement co...
.Having already gathered up the united state legal rights to Capricor Rehabs' late-stage Duchenne mu...
.After dismissing the decision meeting for Applied Therapies' metabolic disorder medication govorest...